CD4 and CD8 lineage T cells develop in the thymus through a series of complex selection events evolved to identify those thymocytes with self-MHC-restricted TCRs and direct their development to the appropriate subset. There has been considerable interest in defining the signaling pathways and transcriptional networks responsible for controlling T cell development. NF-κB transcription factors regulate the survival, function, and development of many cell types, including those of the immune system (Bonizzi and Karin, 2004) . Canonical NF-κB signaling is mediated by the inhibitor of κ B kinase (IKK) complex, comprised of two catalytic subunits, IKK1 (IKKα) and IKK2 (IKKβ), and a regulatory ubiquitin-binding adaptor, NEMO (IKKγ). Phosphorylation by the IKK complex targets inhibitor of κ Bα (IκBα) for degradation by the proteasome, releasing associated NF-κB1 p50/ Rel and NF-κB1 p50/cRel dimers to enter the nucleus and stimulate gene transcription.
CD4 and CD8 lineage T cells develop in the thymus through a series of complex selection events evolved to identify those thymocytes with self-MHC-restricted TCRs and direct their development to the appropriate subset. There has been considerable interest in defining the signaling pathways and transcriptional networks responsible for controlling T cell development. NF-κB transcription factors regulate the survival, function, and development of many cell types, including those of the immune system (Bonizzi and Karin, 2004) . Canonical NF-κB signaling is mediated by the inhibitor of κ B kinase (IKK) complex, comprised of two catalytic subunits, IKK1 (IKKα) and IKK2 (IKKβ), and a regulatory ubiquitin-binding adaptor, NEMO (IKKγ) . Phosphorylation by the IKK complex targets inhibitor of κ Bα (IκBα) for degradation by the proteasome, releasing associated NF-κB1 p50/ Rel and NF-κB1 p50/cRel dimers to enter the nucleus and stimulate gene transcription.
NF-κB has been shown to control T cell development at various checkpoints. Inhibition of NF-κB activity by T cell expression of a degradation-resistant IκBα super-repressor blocks the CD4 CD8 double-negative (DN) to CD4 CD8 double-positive (DP) transition, suggesting a role for NF-κB downstream of the pre-TCR complex in DN thymocytes (Voll et al., 2000) . Super-repressor IκBα expression has also be reported to inhibit positive selection of CD8 SP thymocytes, which have the highest level of detectable NF-κB activity in the thymus (Mora et al., 1999; Hettmann and Leiden, 2000) . Consistent with this, transgenic expression of a constitutively active IKK2 mutant to increase NF-κB in T cells enhances CD8 SP development (Jimi et al., 2008) . Because TCR signals regulate TCRβ selection in DN thymocytes, and positive and negative selection at the DP stages, it is thought that the observed functions of NF-κB are the result of TCR-dependent triggering. However, TCR activation of the IKK complex in peripheral T cells is mediated via a complex comprising Card11, Bcl10, and Malt1 proteins (the CBM complex) that is not required for thymocyte development (Schmidt-Supprian et al., 2004) . This implies that the TCR in thymocytes stimulates IKK independently of the CBM complex or that another receptor is responsible for activating NF-κB in these cells.
In the present study, we reinvestigated the role of NF-κB in thymocyte development using mice in which both Ikk1 and Ikk2 genes had been deleted in early thymic progenitors (IKKΔT). Thymic development was completely arrested at the HSA hi SP stage. In vitro experiments demonstrated that blockade of NF-κB activation specifically sensitized thymocytes to TNF-induced cell death. In line with this, inhibiting TNF signaling with an antibody or deletion of TNF RI rescued the development of SP thymocytes in IKKΔT mice. These results reveal a critical role for TNF in the development of SP T cells in the thymus.
NF-κB activation has been implicated at multiple stages of thymic development of T cells, during which it is thought to mediate developmental signals originating from the T cell receptor (TCR). However, the Card11-Bcl10-Malt1 (CBM) complex that is essential for TCR activation of NF-κB in peripheral T cells is not required for thymocyte development. It has remained unclear whether the TCR activates NF-κB independent of the CBM complex in thymocyte development or whether another NF-κB activating receptor is involved. In the present study, we generated mice in which T cells lacked expression of both catalytic subunits of the inhibitor of κB kinase (IKK) complex, IKK1 and IKK2, to investigate this question. Although early stages of T cell development were unperturbed, maturation of CD4 and CD8 single-positive (SP) thymocytes was blocked in mice lacking IKK1/2 in the T cell lineage. We found that IKK1/2-deficient thymocytes were specifically sensitized to TNF-induced cell death in vitro. Furthermore, the block in thymocyte development in IKK1/2-deficient mice could be rescued by blocking TNF with anti-TNF mAb or by ablation of TNF RI expression. These experiments reveal an essential role for TNF activation of NF-κB to promote the survival and development of single positive T cells in the thymus. To investigate the role of NF-κB signaling in thymocyte development, we used the Cre-Lox system to delete conditional alleles of Ikk1 and Ikk2 genes within the T cell lineage. Previous studies show that thymic development proceeds relatively normally in the absence of either Ikk1 or Ikk2 expression (Schmidt-Supprian et al., 2003; Chen et al., 2015) , even when gene deletion occurs early in T cell development in DN2 thymocytes (Silva et al., 2014) , with the exception of thymic regulatory T cell development that is reduced by lack of either IKK1 or IKK2. This suggests that there is significant redundancy between these two subunits for activating IKK activity and canonical NF-κB signaling. Therefore, to achieve a complete block in IKK function, we generated Ikk1 fx/fx Ikk2 fx/fx mice to delete both kinase subunits, using either huCD2 iCre to delete in DN2 thymocytes (IKKΔT CD2 ) or CD4
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). Cre activity was monitored by the inclusion of Rosa26 RYFP reporter alleles (Srinivas et al., 2001) . Surprisingly, early deletion of IKK genes by huCD2 iCre did not result in any obvious defects in DN or DP development. Number and representation of DN3 and DN4 thymocytes were not obviously perturbed in IKKΔT CD2 mice (Fig. 1 A) . Similarly, subsets of DP thymocytes defined by expression of TCR and CD5 (Saini et al., 2010) were normally represented (Fig. 1 B) . In contrast, the TCR hi SP compartment was profoundly affected. Percentages of both CD4SP and CD8SP were reduced (Fig. 1 C) and analysis of cell phenotype revealed that mature HSA lo SPs were greatly reduced in number in the absence of Ikk genes (Fig. 1 C) . This block in development was also evident in IKKΔT CD4 mice in which gene deletion occurred at the DP stage (Fig. 1 D) . In the periphery, there was a corresponding reduction in the naive T cell compartment in IK-KΔT CD2 mice compared with controls ( Fig. 1 E) . The few naive, memory, and regulatory cells present (Fig. 1 E) were largely Cre reporter YFP-negative (Fig. 1 F) and therefore most likely represent escapants, in which Ikk1 and/or Ikk2 gene deletion was incomplete. Together, these data demonstrate a critical role for IKK1/2 in the development of SP thymocytes, whereas earlier stages of thymocyte development are IKK1/2-independent. These results are consistent with earlier reports on the effects of Nemo deficiency upon development of SP thymocytes (Schmidt-Supprian et al., 2003) .
IKK1/2-deficient thymocytes are specifically sensitive to TNF-induced apoptosis We next investigated which receptors might be responsible for triggering the NF-κB activation required for SP thymocyte development, other than TCR. TNF receptor superfamily (Tnfrsf) members are potent activators of NF-κB, and those receptors with death domains can also recruit the adapter TRA DD and/or FADD to trigger caspase-induced cellular (Vandenabeele et al., 2010) . One possible role for NF-κB in developing thymocytes could be to prevent induction of cell death induced by such receptors. Our previous studies reveal that SP thymocytes express Tnfrsf members TNF receptor I and II, CD27 (Tnfrsf7), TACI (Tnfrsf13b), LIG HTR (Tnfrsf14), GITR (Tnfrsf18), Tnfrsf25, and Tnfrsf26 (Silva et al., 2014) . We therefore asked whether ligands for these receptors could induce apoptosis in IKK1/2-deficient thymocytes, which could account for the phenotype of IKKΔT mice. Thymocytes from IKKΔT CD4 mice were cultured overnight with TNF (ligand for TnfrI and TnfrII), CD27L, APR IL, or BAFF (TACI ligands), LIG HT (LIG HTR ligand), TRA IL (ligand for Tnfrsf26), GIT RL (GITR ligand), or TL1A (ligand for DR3/ Tnfrsf25), and then viability assessed. Thymocyte survival was unaffected by all ligands except TNF which induced a substantial increase in cell death in SP thymocytes (Fig. 2 A) . To examine this in more detail, we measured TNF-induced cell death on different thymic subsets from IKKΔT CD4 mice, as well as WT and Tnfrsf1a
−/− donors as controls. TNF promoted cell death in a small fraction of DP and HSA hi CD4SP subsets from both WT and IKKΔT CD4 donors. In contrast, TNF stimulation had no effect upon cell viability of HSA lo CD4SP or either CD8SP subset from WT mice, but induced high levels of cell death in the same populations from IK-KΔT CD4 mice (Fig. 2 B) . The viability of thymocytes from Tnfrsf1a −/− mice was unaffected by TNF, confirming that TNF RI was required to transmit proapoptotic TNF signals in DP and HSA hi CD4 SP.
The few SP cells that developed in IKKΔT CD4 mice were highly sensitive to TNF-induced cell death in vitro, consistent with earlier studies that IKK2-deficient T cells are sensitive to TNF-induced cell death (Senftleben et al., 2001) . However, development of IKK2-deficient thymocytes is normal (Schmidt-Supprian et al., 2003; Silva et al., 2014) , in contrast to that of IKKΔT mice. Because IKKΔT cells had developed in the absence of IKK1/2, it was unclear whether the sensitivity of SP cells to TNF reflected a normal requirement for IKK1/2 for their survival after TNF stimulation. To investigate this, we analyzed responses of thymocytes from huCD2 iCre Ikk1 fx/fx mice cultured with IKK2-specific inhibitor Bl605906 (Clark et al., 2011) . In the absence of IKK1 protein, IKK2 inhibition results in a near complete block in canonical NF-κB signaling (Clark et al., 2011) . Importantly, thymic development in IKK1-deficient mice is grossly normal (Chen et al., 2015) . Thymocytes from huCD2 iCre Ikk1 fx/fx mice (lacking only IKK1) were resistant to TNF-induced cell death, similar to WT thymocytes. Only a small fraction of HSA hi CD4SP were induced to die by TNF, whereas viability of all other SP subsets were unaffected by TNF (Fig. 2 C) . However, culture with IKK2 inhibitor rendered HSA lo CD4SP and both subsets of CD8SPs from huCD2 iCre Ikk1 fx/fx mice profoundly susceptible to death induction by TNF (Fig. 2 C) . TNF also induced active caspase 8 in cultures of huCD2 iCre Ikk1 fx/fx thymocytes and IKK2 inhibitor, providing evidence that TNF induced apoptotic cell death. Together, these data suggest that TNF RI activation of IKK/NF-κB activity was required to protect thymocytes from TNF-induced apoptosis. The susceptibility of thymic subsets to TNF-induced apoptosis in vitro, as assessed by Bl605906 IC 50 values (Fig. 2 E) , mirrored the phenotype of IKK1/2-deficient thymocytes in vivo. HSA hi CD4SPs were least susceptible to TNF-induced cell death in vitro and were minimally affected in IKKΔT CD4 mice. In contrast, HSA lo CD8SP thymocytes were most sensitive to TNF-induced cell death in the absence of IKK activity and were virtually absent from IKKΔT CD4 mice. Because the IKK complex is known to regulate cell function independently of NF-κB (Yan et al., 2013; Dondelinger et al., 2015) , it was important to confirm that the effects of IKK1/2 deficiency on thymocyte development were actually due to reduced NF-κB activation. First, we confirmed that IKK2 blockade in IKK1-deficient thymocytes did indeed prevent NF-κB activation by TNF (Fig. 2 F) . Second, we analyzed a transgenic mouse strain in which thymocytes express a dominant-negative inhibitor of κB (pLck-IκB-PEST), in which CD8SP development is significantly impaired (Mora et al., 1999) . HSA lo CD4SP, HSA hi CD8SP, and HSA lo CD8SP thymocytes from pLck-IκB-PEST mice were more susceptible to TNF-induced cell death, whereas HSA hi CD4SP remained relatively unaffected by IκB-PEST expression compared with controls (Fig. 2 G) . These results confirm that TNF activation of NF-κB is required for thymocyte survival in vitro. 
Blockade of TNF signaling via TNF RI rescues IKKΔT SP thymocyte development
We next asked whether the susceptibility of SP thymocytes to TNF-induced cell death observed in vitro could account for the abnormal thymic development in mice with impaired NF-κB signaling. IKKΔT CD4 mice were treated with neutralizing anti-TNF mAb for 7 d. This short period of TNF blockade was sufficient to restore both HSA lo CD4SP and total CD8SP thymic subsets in treated mice (Fig. 3 A) . Examining T cells in lymph nodes of treated mice at day 7 revealed a significant increase in the number of naive T cells in anti-TNF-treated mice, suggesting that newly developing SP cells were also able to emigrate to the periphery (Fig. 3 B) . To determine if TNF signaling was transmitted by TNF RI receptor, we additionally generated Tnfrsf1a −/− IKKΔT CD4 mice. Loss of TNF RI expression also restored development of mature SP subsets in IKKΔT CD4 mice (Fig. 3 C) . Enumerating different subsets of thymocytes revealed that anti-TNF treatment resulted in comparable rescue of SP thymic development in IKKΔT CD4 mice to that in Tnfrsf1a −/− IK-KΔT CD4 mice (Fig. 3 D) .
Analyzing the periphery of Tnfrsf1a −/− IKKΔT CD4 mice revealed a substantial increase in numbers of naive T cells compared with IKKΔT CD4 controls (Fig. 3 E) . However, repopulation was still only a fraction of that observed in Cre-WT controls. We have previously shown that NF-κB signaling is required for normal expression of IL-7Rα by naive T cells, which is necessary for their long-term survival (Silva et al., 2014) . Naive T cells from Tnfrsf1a −/− IKKΔT CD4 mice displayed a substantial reduction in IL-7Rα levels compared with controls (Fig. 3 E) . Impaired IL-7Rα expression therefore may explain why Tnfrsf1 deletion in absence of IKK1/2 expression did not rescue naive T cell numbers more efficiently in the periphery.
Lastly, we asked whether the defect in CD8SP development reported in pLck IκB-PEST mice could also be corrected by anti-TNF treatment. Analyzing thymocytes from pLck-IκB-PEST mice revealed that the reduced abundance of CD8SP was a result of a specific reduction in HSA lo CD8SP thymocytes (Fig. 4) , that we also found to be most sensi- tive to TNF-induced cell death in vitro (Fig. 2 E) . Consistent with this, TNF blockade in these mice for 7 d resulted in restoration of normal HSA lo CD8SP compartment (Fig. 4) , suggesting that TNF-induced cell death accounted for the apparent skew in T cell development that had previously been interpreted as a block in selection of CD8 lineage cells.
An absence of TNF gene targets from IKK-deficient SP thymocytes
The mechanisms by which NF-κB activation protects cells from TNF-induced cell death have been intensively studied in a variety of cell types. Several NF-κB target genes have been identified that regulate cell survival after TNF stimulation, including cFLIP, Traf1, Traf2, and members of the inhibitors of apoptosis (IAP) family (Chu et al., 1997; Wang et al., 1998; Kreuz et al., 2001; Micheau et al., 2001; Turner et al., 2007) . Conversely, NF-κB-induced expression of Cyld has been reported to provide negative feedback to TNFR signaling and NF-κB activation (Jono et al., 2004) . Transcriptional profiling was used to investigate whether any of these NF-κB targets might regulate TNF-induced thymocyte survival. TCR transgenic CD8SP thymocytes were stimulated with TNF in vitro for 4 h and gene expression was determined by RNAseq. Analysis of gene expression revealed the induction of several classical NF-κB targets, such as NF-κB1, NF-κB2, inhibitor of κBa (Nfkbia), and Bcl3 (Haskill et al., 1991; Ten et al., 1992; Lombardi et al., 1995; Brocke-Heidrich et al., 2006) , as well as other reported targets Traf1 and Il7r (Schwenzer et al., 1999; Miller et al., 2014 ; Fig. 5 A) . The prosurvival genes, Cflar (cFLIP) and Xiap were not induced by TNF stimulation of thymocytes. Levels of Cyld and Diablo/SMAC mRNAs were unaffected by TNF stimulation. In contrast, the expression of −/− littermates (solid line). Gray fills are IL-7Rα expression by DP thymocytes from WT mice as negative control. FACS data are representative of four or more independent experiments, and bar charts are pooled from four or more independent experiments. ****, P < 0.0001. IKKΔT CD4 mice (n = 4). mRNA was purified and gene expression was determined by RNAseq analysis. Bar charts show mRNA expression level (nRPKM) of the indicated genes. Individual RNAseq libraries were generated from independent cell preparation and treatments. *, P < 0.05. Figure 4 . TNF blockade rescues the developmental block in pLck IκB-PEST mice. pLck IκB-PEST mice were treated with anti-TNF (n = 8; 1 mg, days 0, 2, and 4) or PBS (n = 8) injection as control. At day 7, thymi were analyzed by FACS. Density plots are of CD4 versus CD8 by total live (top row) and HSA versus TCR by CD8SP gated thymocytes from pLck IκB-PEST mice treated with either anti-TNF (αTNF) or PBS as control. Transgene -ve (WT, n = 4) littermates were also analyzed as control. Bar charts show total cell numbers of the indicated thymocyte subset recovered from the indicated treatment groups. Data are pooled from two independent experiments. **, P < 0.01.
Birc3 (cIAP2) mRNA was strongly increased by TNF stimulation, and Birc3 (cIAP2) mRNA to a lesser extent.
To test whether expression of any of these NF-κB target genes was reduced in IKK1/2-deficient thymocytes, we performed RNAseq on sorted CD8SP thymocytes from Tnfrsf1a −/− IKKΔT CD4 and control WT mice. Although TNF RII gene expression (Tnfrsf1b) was modestly induced by TNF in vitro, no modulation was observed in IKKΔT CD4 mice in vivo (Fig. 5) , arguing against a role for modulated TNF RII levels in the rescue of development by TNF blockade. Significantly, those genes found to be positively regulated by TNF in vitro were all expressed at reduced levels in vivo in the absence of IKK1/2 (Fig. 5 B) . Similarly, those potential NF-κB targets that were not regulated in vitro were also unaffected by IKK ablation in vivo (Fig. 5 B) . Together, these data suggest that defective IAP2 and IAP1 expression sensitizes IKK1/2-deficient thymocytes to TNF-induced cell death.
Conclusion
The role of NF-κB signaling during development of conventional T cells has previously been almost exclusively considered in the context of TCR signaling. Our study identifies TNF as the key trigger of NF-κB activation required to promote thymocyte development. CD8 SP thymocytes were especially sensitive to TNF-induced cell death in the absence of NF-κB activation, and this likely accounts for the apparent selective defects in CD8 lineage development previously reported and attributed to altered TCR selection signaling.
We recently showed that Il7r is a NF-κB target gene necessary for long-term survival of peripheral naive T cells (Silva et al., 2014) , and it seems likely that NF-κB regulates other gene targets necessary for normal T cell function. Our study also aligns development of conventional T cells with that of regulatory T cells, which rely upon the cooperative activity of several Tnfrsf members for their development (Mahmud et al., 2014) . Determining whether TNFR cooperates with other Tnfrsf members and the role of NF-κB activation downstream of such receptors will be important areas for future studies. Flow cytometry. Flow cytometric analysis was performed with 2-5 × 10 6 thymocytes and 1-5 × 10 6 lymph node or spleen cells. Cell concentrations of thymocytes, lymph node, and spleen cells were determined with a Scharf Instruments Casy Counter. Cells were incubated with saturating concentrations of antibodies in 100 µl of PBS containing BSA (0.1%) and 1 mM azide (PBS-BSA-azide) for 45 min at 4°C, followed by two washes in PBS-BSA-azide. Phycoerythrin (PE)-conjugated antibody against IL-7Rα, EF450-conjugated antibodies against CD4, APC-conjugated antibody against CD5, PE-Cy5-and PerCPcy5.5-conjugated antibody against TCR (H57-597), APC-Cy7-and APC-conjugated antibody against CD44, pacific orange (PO)-conjugated antibody against CD8, PE-Cy7-conjugated antibody against CD25, and PE-Cy7-conjugated antibody against HSA/ CD24 were purchased from eBioscience. Cell viability was determined using LIVE/DEAD cell stain kit (Invitrogen) and active Caspase 8 was detected using CaspGLOW Red Active Caspase-8 Staining kit (BioVision Inc.), following the manufacturer's protocol. Eight-color flow cytometric staining was analyzed on a FAC SCanto II or LSRFortessa X-20 (BD) instrument, and data analysis and color compensations were performed with FlowJo V9.5.3 software (Tree Star). Data are displayed on log and biexponential displays. For cell sorting, lymphocytes were incubated with the appropriate antibodies for detection of surface markers, and were then purified to >95% purity by high-speed sorting on an FAC SAria flow cytometer (BD).
MAT ERI ALS AND MET HODS
In vitro culture. Thymocytes were cultured at 37°C with 5% CO 2 in RPMI-1640 (Invitrogen) supplemented with 10% (vol/vol) FBS (Invitrogen), 0.1% (vol/vol) 2-mercaptoethanol βME (Sigma-Aldrich), and 1% (vol/vol) penicillin-streptomycin (Invitrogen; RPMI-10). Recombinant TNF, BAFF, LIG HT, APR IL, TRA IL, GIT RL, CD70, and TLA1 were supplemented to cultures at 100 ng/ml unless otherwise state, and were obtained from R&D Systems, with PBS used as vehicle. IKK2 inhibitor Bl605906 was used at 10 µM in DMSO vehicle. Binding of RelA from nuclear extracts of TNF-stimulated thymocytes to NF-κB oligonucleotide was determined by specific ELI SA (Active Motif) according to the manufacturer's instructions.
RNA sequencing. RNA was extracted from the cells using the Isolate II RNA mini kit (Bioline). RNA-seq libraries were prepared for sequencing using Illumina Truseq RNA Library Preparation kit (Illumina) according to the manufacturer's instructions. Samples were sequenced at the MRC National Institute for Medical Research High Throughput Sequencing Facility using an Illumina Genome Analyser IIx, and 36 bp single-end reads were obtained using the Illumina pipeline. Reads were aligned to the Mus musculus genome (mm9 assembly) using CLC Genomic Workbench (V5) with standard settings. Aligned reads were mapped to the Ref Seq database and were normalized using the DESeq method (Anders and Huber, 2010) using Avadis NGS software V1.3.1. After normalization, reads were displayed as reads per kilobase of exon per million reads (RPKM). Data are deposited in ArrayExpress, accession nos. E-MTAB-4778 and E-MTAB-4786.
Statistics. Statistical analysis and figure preparation were performed using Graphpad Prism 6 (v6.0a). Column data compared by nonparametric unpaired two tailed Mann-Witney Student's t test while dose response curves were analyzed by two-way ANO VA. *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001.
